Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

Medicare doesn’t cover all of your health care expenses when you turn 65. Medicare Part A covers inpatient care in hospitals ...

Explore the profound impact of physical work on health and the body at our new major exhibition. We publish thought-provoking books exploring health and human experiences. Our latest titles include ...